← Back to all signals
RESEARCH PAPER ANALYSIS

Clinical Profile, Outcomes, and Predictors of Malignant Pheochromocytoma and Paraganglioma: Insights From a Single-Center Cohort.

AI interpretation is pending for this paper.

Open original publication →
PMID40735853
JournalClinical endocrinology
Publication Date2025-07-30
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Malignant pheochromocytoma and paraganglioma (mPPGL) are not so common and the factors predicting the metastatic behavior are not well understood. METHODS: This retrospective cohort study included 218 patients with PPGL managed at our center over a period of 11 years (2013-2024). The clinical profile and treatment outcomes of patients with mPPGL were studied and were compared with non-metastatic PPGL(non-mPPGL). RESULTS: Thirty-six patients had mPPGL and the median age at diagnosis of metastases was 39.5 years(range 10-62). Twenty-one(58.3%) patients had synchronous metastases and 15(41.7%) developed metachronous metastases after a median duration of 76 months(range 13-270 months) from the diagnosis of the primary tumor. Metastases were detected in 100% of patients who had 18FDG(4/4) and 68 Ga DOTATATE(4/4) PET-CT, 97.2% (35/36) with CT/MRI and 79.3%(23/29) with 131I MIBG scan. Surgery was the primary treatment in 78%, and 131I MIBG therapy was administered to 19(52.8%) patients. Eleven patients succumbed due to metastatic disease and among them nine died within a year of diagnosis of metastases, the median survival at last follow-up was 31.5 months (range 3-96). On comparing mPPGL(n = 36) and non-mPPGL(n = 182), we found that patients with mPPGL had larger tumors (8.8 ± 5.2 vs. 6.3 ± 3.3, p = 0.001), had less frequent adrenergic symptoms and more often had extra-adrenal tumors. CONCLUSION: Malignant PPGLs had a variable clinical course and were amenable to multimodal therapeutic strategies with a favorable outcome in about 67% of the patients. Although mPPGL had larger tumor diameter compared to non-mPPGL, no particular size cut-off could accurately predict metastases. Adjuvant 131I MIBG therapy is a useful treatment option in resource limited settings.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Well-established efficacy of camrelizumab combined with radiofrequency ablation in cirrhotic patients with hepatic cancer. American journal of translational research 63.1 2 Pediatric leukemia: origins, pathogenesis, the role of microenvironment and immunological modulation. Frontiers in immunology 66.9 3 Trapped in "No Man's Land": Navigating clinical trial enrollment as an adult with a WHO Grade 4 pediatric-type glioma. Neuro-oncology advances 61.0 4 Characterization of Groundwater Hydrochemistry and Comprehensive Water Quality Assessment in the Zi River Basin, Northern China. Water environment research : a research publication of the Water Environment Federation 60.9 5 Libman-Sacks Endocarditis as a Noninfectious Cardiac Complication of Acute Promyelocytic Leukemia in an Adolescent. CASE (Philadelphia, Pa.) 47.5 6 "MyLogbook-I Know My Way Around": A Psychological Therapy Program to Enhance Health Literacy and Positive Emotional Adjustment in Pediatric Oncology. Psycho-oncology 70.14 7 Toward uncertainty-aware manual delineation of brain tumours using eye-tracking and image-derived features. Physics and imaging in radiation oncology 62.8 8 Case Report: Awake double-lumen tube intubation and intraoperative ventilation strategy conversion in an obese adolescent with a giant anterior mediastinal teratoma. Frontiers in medicine 47.5 9 Exploring drug sensitivity guided individualized treatment in pediatric spindle cell/sclerosing rhabdomyosarcoma. Frontiers in pharmacology 75.5 10 Virtual reality for reducing pain, anxiety, and distress in children, adolescents, and young adults with cancer: a systematic review and meta-analysis of randomized controlled trials. Frontiers in psychiatry 77.0 11 Timing of orchiopexy in children with congenital undescended testis in Latin America: A multicenter retrospective study. Journal of pediatric urology 72.4 12 Endoscopic Resection of Juvenile Nasopharyngeal Angiofibroma With Extended Maxillectomy and Pterygopalatine Fossa Exposure. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 54.0 13 Efficacy and Safety of Durvalumab plus Tremelimumab for Unresectable Hepatocellular Carcinoma: A Real-World Multicenter Observational Study. Oncology research 66.7 14 From genotype to outcome in optic pathway gliomas: Biology, biomarkers, targeted therapy, and future directions. Cancer genetics 74.0 15 Gaps in Population Life Course Phenotype Trajectories Underlying Major Noncommunicable Diseases: A Scoping Review. International journal of population data science 63.9 16 Mutations of the DICER1 gene among children and adolescents with thyroid cancer: a systematic review. Pediatric research 72.5 17 Total body irradiation versus chemotherapy before stem cell transplantation in children aged two to four with acute lymphoblastic leukemia-an EBMT pediatric diseases working party study. Leukemia 53.44 18 Oncogenic DHX15 mutation enhances mitochondrial metabolism and sustains leukemia stemness. Leukemia 66.4 19 Social vulnerability is not associated with reduced access to hematopoietic cell transplantation among referred pediatric patients with hematologic malignancies. Bone marrow transplantation 47.5 20 Clinical characteristics and treatment strategies of brainstem lesion in children with neurofibromatosis type 1. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 67.74 21 It's hard enough having cancer as an adolescent or young adult, but what about its financial impact? Journal of cancer survivorship : research and practice 59.6 22 Declining treatment-related and overall mortality in children with newly diagnosed advanced-stage non-Hodgkin lymphoma treated in a paediatric cancer centre during 2013-2024, Shanghai, China. British journal of haematology 71.04 23 Cervical cancer screening predictors in Tanzania: a variance component models' approach of national survey 2022. Medicine 63.4 24 The economic costs of unpaid cancer caregiving: A qualitative study. Palliative medicine 56.0 25 Practices of Antifungal Prophylaxis Among Italian Pediatric Oncology-Hematology Centers. EJHaem 75.5 26 Sinusoidal obstruction syndrome in children with B-acute lymphoblastic leukemia (B-ALL) treated with inotuzumab ozogamicin: Results from the ITCC-059 trial. HemaSphere 47.5 27 Cell-of-origin Discovery in Infant Leukemia through Integration of 3D Models and Patient Transcriptomic Data. Journal of visualized experiments : JoVE 57.6 28 Unmet Needs of Adolescent and Young Adult Cancer Survivors Treated in West Virginia: A Qualitative Analysis of Open-Ended Survey Responses. Journal of adolescent and young adult oncology 61.52 29 Uncovering the Use of Family-Centered Care Interventions Among Children With Cancer and Their Families: A Scoping Review of the Characteristics of Interventions and Effectiveness. Journal of family nursing 73.1 30 Performance of International Ovarian Tumor Analysis Simple Rules and Ovarian-Adnexal Reporting and Data System for classifying benign and malignant pediatric adnexal lesions using ultrasound. Pediatric radiology 63.0 31 "I never thought to bring them up to the doctor": examining symptom appraisal, help-seeking behaviors, and diagnostic delays among young adults with cancer. Cancer causes & control : CCC 59.2 32 Assessing the Impact of Rituximab on Treatment Outcomes in Pediatric Advanced Mature B-Non Hodgkin Lymphoma - Correspondence. Indian journal of pediatrics 50.74
PATIENT-FRIENDLY SUMMARY

Clinical Profile, Outcomes, and Predictors of Malignant Pheochromocytoma and Paraganglioma: Insights From a Single-Center Cohort.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic